Dr. Julie Shaw, PhD, FCACB
Dr. Shaw completed her undergraduate and master’s degree at Queen’s University, followed by a PhD in Laboratory Medicine from the University of Toronto. After completing her PhD, she spent two years as a research fellow in the Centre for Reproductive Biology at The University of Edinburgh. Upon returning to Canada, Dr. Shaw completed her fellowship in Clinical Biochemistry at The University of Toronto.
She moved to Ottawa in 2012 and began working with EORLA. She is currently the Regional Discipline Lead for Biochemistry and Point-of-Care Testing (POCT). Dr. Shaw is an Associate Professor in the Department of Pathology and Laboratory Medicine at The University of Ottawa. Her areas of interest for research are POCT quality assurance and the use of POCT glucose results to monitor glycemic control of hospitalized patients. More recently, she has been working on SARS-CoV-2 seroprevalence studies. Dr. Shaw currently chairs the POCT interest group for the Canadian Society of Clinical Chemists (CSCC) and is the CSCC representative on the International Federation of Clinical Chemistry (IFCC) POCT working group.